...
首页> 外文期刊>Annals of surgical oncology >Laparoscopic liver surgery for patients with hepatocellular carcinoma.
【24h】

Laparoscopic liver surgery for patients with hepatocellular carcinoma.

机译:腹腔镜肝癌手术治疗肝细胞癌。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Laparoscopic hepatectomy is feasible for hepatocellular carcinoma (HCC) today. This is a retrospective study of the patients with HCC treated by liver resection with a totally laparoscopic approach. METHODS: This study recruited 116 patients (92 male, 24 female) that underwent laparoscopic liver resection (LR) for HCC. Patients were divided into two groups: group I: (n = 97, 78 male,19 female) those with a volume of resection less than two segments; group II: (n = 19, 14 male, 5 female) those with a volume of resection of more than two segments. The distribution of the tumor-node-metastasis (TNM) stage of patients in the two groups was not significantly different. RESULTS: Patients resumed full diet on the second or third day after the operation, and the average length of hospital stay was 6 days. The operation time was 152.4 +/- 336.3 min and 175.8 +/- 57.4 min, while blood loss was 101.6 +/- 324.4 mL and 329.2 +/- 338.0 ml, for groups I and II, respectively. Five patients (5.2%) in group I and three patients (15.8%) in group II required blood transfusion (p = 0.122). The mortality rate was zero among our patients and complication rates were 6.2% and 5.2% for groups I and II, respectively. The 1-year, 3-year, and 5-year survival rates were 85.4%, 66.4%, and 59.4% for group I, and 94.7%, 74.2%, and 61.7% for group II, respectively, with no significant difference between two groups (p = 0.1237). CONCLUSION: Laparoscopic liver resection is a procedure of significant risk and is more technically demanding in comparison with traditional open method. There was no significant difference in survival rates, based on the volume of resection. Laparoscopic surgery should be performed in selected patients as the postoperative quality of life of patients is better than that with open resection.
机译:背景:腹腔镜肝切除术目前可用于肝细胞癌(HCC)。这是一项采用完全腹腔镜方法通过肝切除术治疗的HCC患者的回顾性研究。方法:本研究招募了116例行HCC腹腔镜肝切除术(LR)的患者(男92例,女24例)。患者分为两组:第一组(n = 97,男性78,男性19,女性),其切除量少于两个节段。第二组:(n = 19,男性14,女性5)是那些切除量超过两个部分的患者。两组患者的肿瘤淋巴结转移(TNM)阶段的分布没有显着差异。结果:患者在术后第二天或第三天恢复完全饮食,平均住院时间为6天。 I组和II组的手术时间分别为152.4 +/- 336.3分钟和175.8 +/- 57.4分钟,失血量分别为101.6 +/- 324.4 mL和329.2 +/- 338.0 ml。第一组的五名患者(5.2%)和第二组的三名患者(15.8%)需要输血(p = 0.122)。 I组和II组的死亡率为零,并发症发生率分别为6.2%和5.2%。第一组的1年,3年和5年生存率分别为85.4%,66.4%和59.4%,第二组分别为94.7%,74.2%和61.7%,两者之间无显着差异两组(p = 0.1237)。结论:腹腔镜肝切除术是一种具有较高风险的手术,与传统的开放式手术相比,其技术要求更高。根据切除量,生存率无显着差异。选择的患者应进行腹腔镜手术,因为患者的术后生活质量优于开放切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号